Tornalate

Tornalate

a trademark for an orally inhaled bronchodilator (bitolterol mesylate).
Mentioned in ?
References in periodicals archive ?
2 percent and Tornalate Metered Dose Inhaler (MDI).
2 percent and the promotion of Tornalate Metered Dose Inhaler in the fast- growing beta agonist segment of the asthma market.
According to Cam Garner, president and chief executive officer, "Dura's introduction of two patented Tornalate products this quarter marked a major milestone.
Tornalate will be marketed by Dura's 92- member national field sales force which targets respiratory specialists.
Tornalate Inhalation Solution adds a bronchodilator beta agonist to Dura's product line and is prescribed in the asthma drug market.
Tornalate Inhalation Solution sales will also support sales of Dura's Tornalate Metered Dose Inhaler (MDI), also recently licensed from Sterling Winthrop Inc.
The benefits of Tornalate include rapid and pronounced bronchodilation (opening of the airways in the lung) and duration of action.
Tornalate (bitolterol mesylate) was developed by Sterling Winthrop Inc.